Albany Molecular Research, Inc. (AMRI) Appoints New President, India Operations and New Director of Project Management - Pharmaceutical Services

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that Mr. Subramanyam Maddala has joined the company as President, India Operations. Mr. Maddala assumes leadership for AMRI’s Indian API manufacturing operations as well as responsibility for AMRI facility operations in Hyderabad and Aurangabad, India.

MORE ON THIS TOPIC